Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |